Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
SOPH
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
prnewswire.com
5 hours ago
prnewswire.com
6 hours ago
prnewswire.com
6 hours ago
seekingalpha.com
14 hours ago
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-0.22
vs -0.33
Q1.23
N/A
-0.31
vs -0.40
Q2.23
N/A
-0.33
vs -0.39
Q3.23
N/A
-0.21
vs -0.36
Q4.23
N/A
-0.37
vs -0.22
Q1.24
N/A
-0.21
vs -0.31
Q2.24
N/A
-0.23
vs -0.33
Q3.24
N/A
-0.28
vs -0.21
Q4.24
N/A
-0.22
vs -0.37
Q1.25
N/A
-0.23
vs -0.21
Sales Growth
YoY
Current
Estimates
Q4.22
+22%
13.4M vs 10.9M
Q1.23
+29%
14M vs 10.9M
Q2.23
+29%
15.1M vs 11.7M
Q3.23
+40%
16.3M vs 11.6M
Q4.23
+27%
17M vs 13.4M
Q1.24
+13%
15.8M vs 14M
Q2.24
+5%
15.8M vs 15.1M
Q3.24
-3%
15.9M vs 16.3M
Q4.24
+6%
18.1M vs 17M
Q1.25
+9%
17.3M vs 15.8M
Return on Equity
QoQ
Q4.22
-7%
-0.07
vs -0.11
Q1.23
-11%
-0.11
vs -0.07
Q2.23
-12%
-0.12
vs -0.11
Q3.23
-9%
-0.09
vs -0.12
Q4.23
-16%
-0.16
vs -0.09
Q1.24
-10%
-0.10
vs -0.16
Q2.24
-13%
-0.13
vs -0.10
Q3.24
-16%
-0.16
vs -0.13
Institutionnal Ownership
QoQ
Q4.22
32
32
vs 34
-6%
Q1.23
34
34
vs 32
6%
Q2.23
35
35
vs 34
3%
Q3.23
34
34
vs 35
-3%
Q4.23
37
37
vs 34
9%
Q1.24
32
32
vs 37
-14%
Q2.24
31
31
vs 32
-3%
Q3.24
32
32
vs 31
3%
Quote Panel
Key Metrics
Forecast
386%2025-Revenue
-173%2025-EPS
-486%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
Morgan Stanley
downgradePrevious: Not converted
2024-08-07
Now: Equal-Weight
Morgan Stanley
downgradePrevious: Not converted
2024-08-07
Now: Positive
Guggenheim
initialisePrevious: Not converted
2024-06-27
Now: Buy
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
NASDAQ
Unprofitable
Unprofitable
0.04Â ( 1.20%)
Relative Strenght
16
Volume Buzz
-62%
Earning Acce
No
Dist 52w H.
54%Relative Strength
SOPH
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|